Dongguan Enxin Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Dongguan Enxin Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AIDXVBN. The owner is based in Dongguan, Guangdong.

Room 402, Building 1

No. 411 Qingxi Science and Technology Road, Qingxi Town

Dongguan, Guangdong 523000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AIDXVBN
AIDXVBN
Registered 2025

Trademark Classifications

Dongguan Enxin Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Dongguan Enxin Technology Co., Ltd. have?

Dongguan Enxin Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Dongguan Enxin Technology Co., Ltd. file in?

Dongguan Enxin Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Dongguan Enxin Technology Co., Ltd.'s most well-known trademarks?

Dongguan Enxin Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as AIDXVBN. These are among 1 currently registered trademark in the portfolio.

What is Dongguan Enxin Technology Co., Ltd.'s trademark registration success rate?

Dongguan Enxin Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.